Machine Learning for Diagnosis and Screening of Chronic Lymphocytic Leukemia Using Routine Complete Blood Count (CBC) Results

Stud Health Technol Inform. 2023 Jun 29:305:279-282. doi: 10.3233/SHTI230483.

Abstract

The comprehensive epidemiology and global disease burdens reported recently suggest that chronic lymphocytic leukemia (CLL) constitutes 25-30% of leukemias thus being the most common leukemia subtype. However, there is an insufficient presence of artificial intelligence (AI)-based techniques for CLL diagnosis. The novelty of this study is in the investigation of data-driven techniques to leverage the intricate CLL-related immune dysfunctions reflected in routine complete blood count (CBC) alone. We used statistical inferences, four feature selection methods, and multistage hyperparameter tuning to build robust classifiers. With respective accuracies of 97.05%, 97.63%, and 98.62% for Quadratic Discriminant Analysis (QDA), Logistic Regression (LR), and XGboost (XGb)-based models, CBC-driven AI methods promise timely medical care and improved patient outcome with lesser resource usage and related cost.

Keywords: Chronic lymphocytic leukemia; machine learning; routine blood test.

MeSH terms

  • Artificial Intelligence
  • Blood Cell Count
  • Discriminant Analysis
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell* / diagnosis
  • Machine Learning